Technology

IVERIC

$5.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-1.12%) Today
$0.00 (0.00%) As of 10:31 AM UTC after-hours

Why Robinhood?

You can buy or sell IVERIC and other stocks, options, and ETFs commission-free!

About ISEE

IVERIC bio, Inc. Common Stock, also called IVERIC, is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY. The listed name for ISEE is IVERIC bio, Inc. Common Stock.

CEO
Glenn P. Sblendorio
Employees
38
Headquarters
New York, New York
Founded
2007
Market Cap
494.20M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
811.41K
High Today
$5.37
Low Today
$5.21
Open Price
$5.31
Volume
847.94K
52 Week High
$7.98
52 Week Low
$2.64

Collections

ISEE Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, Pre-Market

You May Also Like

DGNR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure